Objective: The objective of our study was to compare dose-length product (DLP)-based estimates of effective dose with organ dose-based calculations using tissue-weighting factors from publication 103 of the International Commission on Radiological Protection (ICRP) or dual-energy CT protocols.
Materials And Methods: Using scanner- and energy-dependent organ dose coefficients, we calculated effective doses for CT examinations of the head, chest, coronary arteries, liver, and abdomen and pelvis using routine clinical single- or dual-energy protocols and tissue-weighting factors published in 1991 in ICRP publication 60 and in 2007 in ICRP publication 103. Effective doses were also generated from the respective DLPs using published conversion coefficients that depend only on body region. For each examination type, the same volume CT dose index was used for single- and dual-energy scans.
Results: Effective doses calculated for CT examinations using organ dose estimates and ICRP 103 tissue-weighting factors differed relative to ICRP 60 values by -39% (-0.5 mSv, head), 14% (1 mSv, chest), 36% (4 mSv, coronary artery), 4% (0.6 mSv, liver), and -7% (-1 mSv, abdomen and pelvis). DLP-based estimates of effective dose, which were derived using ICRP 60-based conversion coefficients, were less than organ dose-based estimates for ICRP 60 by 4% (head), 23% (chest), 37% (coronary artery), 12% (liver), and 19% (abdomen and pelvis) and for ICRP 103 by -34% (head), 37% (chest), 74% (coronary artery), 16% (liver), and 12% (abdomen and pelvis). All results were energy independent.
Conclusion: These differences in estimates of effective dose suggest the need to reassess DLP to E conversion coefficients when adopting ICRP 103, particularly for scans over the breast. For the evaluated scanner, DLP to E conversion coefficients were energy independent, but ICRP 60-based conversion coefficients underestimated effective dose relative to organ dose-based calculations.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.2214/AJR.09.3462 | DOI Listing |
Assay Drug Dev Technol
January 2025
Institute of Pharmaceutical Research, GLA University, Mathura, India.
J Interv Card Electrophysiol
January 2025
Department of Cardiovascular Medicine, Dokkyo Medical University, 880 Kitakobayashi, Mibu, Shimotsugagun, Tochigi, 321-0293, Japan.
Background: The conventional mapping approach for the atrioventricular accessory pathway (AP) involves point-by-point mapping to identify the connection sites of the AP to the atria or ventricle and accurate interpretation of local electrograms. Omnipolar mapping technology (OMT) explains how vector and wave speed are produced by using both unipolar and bipolar signals to obtain omnipolar signals, directions, and conduction velocity. The aim of this study is to verify the effectiveness of OMT for catheter ablation of AP.
View Article and Find Full Text PDFVet Res Commun
January 2025
Biochemistry, Veterinary Biosciences Department, Veterinary Faculty, Universidad de la República, Ruta 8, Km 18 y Ruta 102, Montevideo, 13000, Uruguay.
The aim was to study the effect of long-acting analogue of oxytocin (Carbetocin) on cervical collagenolysis of MAP-eCG synchronized ewes. At the expected time of artificial insemination, five ewes were slaughtered (n = 5) and their cervical explants (100-200 mg) were incubated during 12 h with MEM supplemented with 0, 8, 16, 32 and 64 ng/mL of Cb. Activities of activated and latent forms of matrix metalloproteinases-2 and - 9 (MMP-2 and MMP-9, respectively) in the supernatant were determined by a SDS-PAGE zymography and prostaglandin E2 concentration by immunoassay.
View Article and Find Full Text PDFCancer Chemother Pharmacol
January 2025
Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.
Background: ATR is an apical DDR kinase activated at damaged replication forks. Elimusertib is an oral ATR inhibitor and potentiates irinotecan in human colorectal cancer models.
Methods: To establish dose and tolerability of elimusertib with FOLFIRI, a Bayesian Optimal Interval trial design was pursued.
Radiat Environ Biophys
January 2025
Department of Environmental Health Sciences, #820-11, Slot, Fay W. Boozman College of Public Health, University of Arkansas for Medical Sciences, 4301 W. Markham Str, Little Rock, AR, 72205, USA.
Most studies on the effects of galactic cosmic rays (GCR) have relied on terrestrial irradiation using spatially homogeneous dose distributions of mono-energetic beams comprised of one ion species. Here, we exposed mice to novel beams that more closely mimic GCR, namely, comprising poly-energetic ions of multiple species. Six-month-old male and female C57BL/6J mice were exposed to 0 Gy, 0.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!